NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹2,180 Cr |
Mar2024 | ₹1,833 Cr |
Mar2023 | ₹1,580 Cr |
Mar2022 | ₹1,383 Cr |
Mar2021 | ₹1,325 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,180 Cr | 18.95 | |
Mar2024 | ₹1,833 Cr | 16.00 | |
Mar2023 | ₹1,580 Cr | 14.19 | |
Mar2022 | ₹1,383 Cr | 4.43 | |
Mar2021 | ₹1,325 Cr | - |
Compare Total Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,583.0 Cr | -2.9% | 14.8% | 64.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -2.9% |
14.8% |
64.8% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses